REAL LIFE DATA FROM THE FIRST LINE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA: EXPERIENCE OF A THIRD LEVEL CENTER

被引：0
|
作者：
Sanchez-Raga, J. M. [1 ]
Perez-Montana, A. [1 ]
Beltran, N. [1 ]
Ros, T. [1 ]
Boyeras, B. [1 ]
Martorell, C. [1 ]
Gutierrez, A. [1 ]
Sampol, A. [1 ]
机构：
[1] Hosp Univ Son Espases, Palma De Mallorca, Spain
来源：
HAEMATOLOGICA | 2019年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-008
引用
收藏
页码：194 / 194
页数：1
相关论文
共 50 条
  • [1] REAL LIFE STUDY OF THE EFFICACY AND RESPONSE TO FIRST LINE TREATMENT IN PATIENTS WITH MULTIPLE MYELOMA TRANSPLANT CANDIDATES. EXPERIENCE OF A CENTER
    Suarez, A.
    Luzardo, H.
    Guerra, L.
    Perera, M.
    Torres, M.
    Lopez, J.
    Gonzalvez, J.
    Perez, L.
    Maite Gomez, C.
    Lemes, A.
    Gonzalez, E.
    Saez, Ma N.
    Jimenez, S.
    HAEMATOLOGICA, 2018, 103 : 120 - 120
  • [2] REAL-LIFE STUDY OF EFFICACY AND RESPONSE TO FIRST LINE TREATMENT IN PATIENTS WITH MULTIPLE MYELOMA CANDIDATES FOR TRANSPLANTATION. EXPERIENCE OF A CENTER
    Suarez Cabrera, A.
    Luzardo Henriquez, H.
    Gonzalvez, J.
    Perez, L.
    Guerra, L.
    Perera, M.
    Torres, M.
    Gomez Casares, M. T.
    Lemes, A.
    Gonzalez Perez, E.
    Saez Perdomo, M. N.
    Molero Labarta, T.
    Bravo de Laguna, Jimenez S.
    HAEMATOLOGICA, 2019, 104 : 20 - 20
  • [3] REAL EXPERIENCE OF TREATMENT WITH DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE FIRST LINE AND IN RECALL/REFRACTORY
    Fernandez, Moreno F.
    Sole, Rodriguez M.
    Dominguez, Rodriguez J. F.
    HAEMATOLOGICA, 2020, 105 : 367 - 367
  • [4] BORTEZOMIB IN THE FIRST-LINE TREATMENT OF MULTIPLE MYELOMA: THE EXPERIENCE OF A CENTER
    Mendes, M. J.
    Ferreira, G.
    Saturnino, H.
    Duarte, M.
    Almeida, J. C.
    Arajo, L. F.
    Ribeiro, M. L.
    HAEMATOLOGICA, 2015, 100 : 735 - 735
  • [5] FIRST LINE TREATMENT OF HODGKIN'S LYMPHOMA IN HIV+ PATIENTS. EXPERIENCE OF A THIRD LEVEL CENTER
    de Antonio Ruben, Gomez
    Miguel, Arguello-Tomas
    Lois Teresa, Aldamiz-Echevarria
    Picado Francisco, Tejerina
    Romero Cristina, Diez
    Latorre Leire, Perez
    Chiara, Fanciulli
    Palanca Javier, Menarguez
    Jose Luis, Diez-Martin
    Oreiro Mariana, Bastos
    HAEMATOLOGICA, 2021, 106 (10) : 53 - 54
  • [6] REAL LIFE EXPERIENCE WITH FIRST-LINE THERAPY IN ELDERLY MULTIPLE MYELOMA PATIENTS: CONVENTIONAL OR BORTEZOMIB-BASED? DOUBLE TREATMENT OR TRIPLE TREATMENT?
    Demirsoy, Esra Terzi
    Geduk, Ayfer
    TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2022, 25 (01): : 58 - 67
  • [7] Second- and third-line treatment strategies in multiple myeloma: a referral-center experience
    Sarah Goldman-Mazur
    Alissa Visram
    S. Vincent Rajkumar
    Prashant Kapoor
    Angela Dispenzieri
    Martha Q. Lacy
    Morie A. Gertz
    Francis K. Buadi
    Suzanne R. Hayman
    David Dingli
    Taxiarchis Kourelis
    Wilson Gonsalves
    Rahma Warsame
    Eli Muchtar
    Nelson Leung
    Robert A. Kyle
    Shaji K. Kumar
    Blood Cancer Journal, 12
  • [8] Second- and third-line treatment strategies in multiple myeloma: a referral-center experience
    Goldman-Mazur, Sarah
    Visram, Alissa
    Rajkumar, S. Vincent
    Kapoor, Prashant
    Dispenzieri, Angela
    Lacy, Martha Q. Q.
    Gertz, Morie A. A.
    Buadi, Francis K. K.
    Hayman, Suzanne R. R.
    Dingli, David
    Kourelis, Taxiarchis
    Gonsalves, Wilson
    Warsame, Rahma
    Muchtar, Eli
    Leung, Nelson
    Kyle, Robert A. A.
    Kumar, Shaji K. K.
    BLOOD CANCER JOURNAL, 2022, 12 (12)
  • [9] DESCRIPTIVE ANALYSIS OF THE CARFILZOMIB TOXICITY PROFILE IN PATIENTS WITH MULTIPLE MYELOMA. EXPERIENCE IN A THIRD LEVEL CENTER
    Gutierrez Lopez de Ocariz, X.
    Cuellar Perez-Avila, C.
    Zamanillo Herreros, I
    Iniguez Garcia, R.
    Poza Santaella, M.
    Alonso Fernandez, R.
    Sanchez Pina, J. M.
    Gonzalez Medina, J.
    Buenaventura Buendia, B.
    De Nicolas Sol, R.
    Vera Guerrero, E.
    Hidalgo Soto, M.
    Lopez Munoz, N.
    Lahuerta Palacios, J. J.
    Martinez Lopez, J.
    HAEMATOLOGICA, 2019, 104 : 201 - 202
  • [10] A REAL LIFE SINGLE CENTER EXPERIENCE OF DARATUMUMAB, LENALDOMIDE AND DEXAMETHASONE COMBINATION IN MULTIPLE MYELOMA PATIENTS
    Attucci, I.
    Formica, G.
    Pilerci, S.
    Buzzichelli, A.
    Messeri, M.
    Vannucchi, A. M.
    Antonioli, E.
    HAEMATOLOGICA, 2021, 106 (10) : 165 - 165
12345